Fresenius Medical Care AG (FMS) Cost of Revenue (2009 - 2025)

Fresenius Medical Care AG's Cost of Revenue history runs 17 years deep, the most recent figure standing at $4.3 billion for Q4 2025.

• In Q4 2025, Cost of Revenue rose 5.13% year-over-year to $4.3 billion; the TTM figure through Dec 2025 stood at $10.7 billion (up 64.64% YoY), while the FY2025 annual figure was $17.0 billion, up 9.08% from the prior year.
• Cost of Revenue was $4.3 billion for Q4 2025 at Fresenius Medical Care AG, up from $1.3 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $4.3 billion in Q4 2025 to a low of $145.6 million in Q1 2024.
• Historically, Cost of Revenue has averaged $3.1 billion across 5 years, with a median of $3.8 billion in 2022.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue sank 96.19% in 2024, then jumped 2571.74% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $3.8 billion in 2021, then decreased by 2.21% to $3.7 billion in 2022, then gained by 5.14% to $3.9 billion in 2023, then increased by 4.12% to $4.1 billion in 2024, then advanced by 5.13% to $4.3 billion in 2025.
• The last three Cost of Revenue figures came in at $4.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.2 billion (Q2 2025), per Business Quant data.